Investigating ways to delay the onset of nearsightedness in children
Official title: Feasibility of study to delay myopia onset
Funded at Ohio State University · NIH-10691555 · Data updated 2026-11-12
This study is looking for ways to help kids aged 6 to 11 who might develop nearsightedness by testing if low concentration atropine eye drops can slow it down before it starts, which could help keep their eyes healthy as they grow up.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project start | September 1, 2022 |
| Project end | August 31, 2025 |
| Funding year | 2023 |
| Award (this year) | $235,543 |
| NIH project number | 5R34EY033395-02 |
| Project ID | NIH-10691555 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are children aged 6 to 11 who are at risk of developing myopia.
✕Less likely to help
Patients who are already diagnosed with myopia or are older than 11 years may not benefit from this research.
What this research studies
This research focuses on finding effective methods to delay the onset of myopia, particularly in children aged 6 to 11 who are at risk of developing this condition. The study will explore the feasibility of using low concentration atropine eye drops to potentially slow down the progression of myopia before it begins. By assessing the ability to enroll participants and conduct a future clinical trial, the research aims to establish a foundation for preventing myopia-related complications in adulthood. If successful, this could lead to significant improvements in eye health and quality of life for children.
Why it matters
Potential benefit: If successful, this research could help reduce the risk of developing severe myopia and its associated complications in children.
How similar studies have gone: Previous studies have shown promising results with atropine in controlling myopia, indicating that this approach has potential based on existing evidence.
Where this research is happening
-
Ohio State University
Columbus, United States Active
Researchers
- Principal investigator: Walline, Jeffrey Jay — Ohio State University
- Study coordinator: Walline, Jeffrey Jay
Related research
Other NIH-funded projects on the same topics.
-
Sulfated molecules in the back of the eye and how they shape myopia progression
This grant studies how losing certain building blocks in the eye’s outer layer may affect eye shape and the worsening of nearsightedness in pig eyes to model human disease.
-
Understanding how myopia and glaucoma are connected through eye mechanics
This study looks at how eye growth in myopia may influence glaucoma risk and what markers could identify it early.
-
Topical eyedrops to slow myopia progression in children
A new eyedrop, IVMED-85, is being studied to help slow down myopia in kids by strengthening the eye’s tissues through a copper-related mechanism.
-
Diagnostic Innovations in Glaucoma for High Myopia
A study to improve early detection of open-angle glaucoma in people with high myopia using advanced eye imaging.
-
PICNIC: Factors inside the eye linked to childhood near-sightedness
Researchers are studying how eye structure and vision in young children may predict who will develop myopia, aiming to understand why some kids become nearsighted.
-
Peripheral vision factors behind kids’ nearsightedness
A study with children explores how outer-edge eye signals and eye optics affect the worsening of nearsightedness and whether new lenses and tools can help slow or prevent it.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.